UNICEF opens a femtech funding call offering up to US$100,000
Applications close on 4 November 2026; a functional prototype, eligible country registration and a commitment to open source are central requirements.
Evidence · Published 15 October 2026
A 300-million-test study maps changes across the body at menopause
A Nature Medicine analysis maps changes around the final menstrual period; independent experts caution against reading its “cliff” metaphor as inevitable decline.
Read the article ↗Photo: Adobe Stock
The latest news
What changed in women's health.
What it means.
Independent women’s-health reporting on what changed, why it matters and what to watch next.
Midi expands virtual care for UTIs, bacterial vaginosis and yeast infections
The new service combines acute appointments with follow-up when recurring symptoms need further assessment.
Collective X raises $3.2M to put women’s health evidence behind digital products
Co-founded by Stacy Sims, the platform licenses female-specific research intelligence to health and performance companies through an API.
Allara raises $30M to expand integrated, insurance-covered women’s healthcare
The virtual-care company plans to expand clinical technology, partnerships and research across hormonal, metabolic and reproductive health.
Health & science
Evidence before excitement.
Research, medicine and technology—reported with the limits, source and unanswered questions intact.
Collective X raises $3.2M to put women’s health evidence behind digital products
Co-founded by Stacy Sims, the platform licenses female-specific research intelligence to health and performance companies through an API.
A 300-million-test study maps changes across the body at menopause
A Nature Medicine analysis maps changes around the final menstrual period; independent experts caution against reading its “cliff” metaphor as inevitable decline.
A large cohort study documents first endometriosis diagnoses after menopause
The Nurses’ Health Study II analysis challenges a narrow age-based picture of the disease, while distinguishing diagnosis from disease onset.
Policy & access
The system shapes the outcome.
Health policy, regulation, care delivery and the decisions that determine who can access care.
Midi expands virtual care for UTIs, bacterial vaginosis and yeast infections
The new service combines acute appointments with follow-up when recurring symptoms need further assessment.
Allara raises $30M to expand integrated, insurance-covered women’s healthcare
The virtual-care company plans to expand clinical technology, partnerships and research across hormonal, metabolic and reproductive health.
FDA creates a class II path for home-collected molecular STI tests
The classification gives molecular tests using home-collected specimens a special-controls pathway rather than treating each product as a one-off.
From the archive
The women's health news archive starts in January 2025.
Historical news publications use the source or event date and are clearly marked as archive reporting.
Explore 20 archive news publications ↗
EndoSure gains a European CE mark—but its evidence questions are not settled
The non-invasive endometriosis test can be marketed in the EU, while US use remains research-only and independent clinical validation is still limited.
The endometriosis peptide ENDO-205 can now begin human testing
FDA clearance of an investigational application allows a planned Phase 1 study to proceed; it is not approval of the treatment, and no human efficacy data have been reported.
FDA approves the first generic low-dose estradiol vaginal insert
The generic version of Imvexxy adds another potential access route for painful sex associated with menopausal vulvar and vaginal atrophy.
WHO issues its first global guideline on infertility care
Forty recommendations address prevention, diagnosis, staged treatment, psychosocial support and the affordability of fertility care.